Khadim Dioukhane - Organic Chemistry Laboratory (LCO), Faculty of Sciences Dhar El Mahraz–Sidi Mohammed Ben Abdellah University, Fez ۳۰۰۰۰, Morocco
Hanane Touijer - Biotechnology Laboratory, Faculty of Sciences Dhar El Mahraz–Sidi Mohammed Ben Abdellah University, Fez ۳۰۰۰۰, Morocco
Anouar Alami - Biotechnology Laboratory, Faculty of Sciences Dhar El Mahraz–Sidi Mohammed Ben Abdellah University, Fez ۳۰۰۰۰, Morocco
Hicham Bekkari - Biotechnology Laboratory, Faculty of Sciences Dhar El Mahraz–Sidi Mohammed Ben Abdellah University, Fez ۳۰۰۰۰, Morocco
Najoua Benchemsi - Biotechnology Laboratory, Faculty of Sciences Dhar El Mahraz–Sidi Mohammed Ben Abdellah University, Fez ۳۰۰۰۰, Morocco

The compounds used in this study, TET and OXM, were tested in vitro for their antibacterial activities against isolated strains from the hospital environment (S. aureus H, E. coli H and K. pneumoniae H) and reference strains (S. aureus A, E. coli A, B. subtilis A and P. aeruginosa A). The calculation of the MBC/minimum inhibitory concentration ratio of the products TET and OXM showed that the two products have a bactericidal effect on the strains tested.

Antibacterial Activity, tetrazole, oxime